Sign In
test

Oshrat Levi

Sphera Funds Management Ltd.

Assets Managed
$629.683M
Holdings
95
Last Quarter
2026 - Q1
Filed Date
1d ago
Growth Rate
21.73%(2Q avg: 15.43%)
Sustained Growth
3 quarters

Portfolio positions

This chart displays the top 10 holdings in Sphera Funds Management Ltd.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 95 positions.

Assets under management

The assets under management (AUM) of Sphera Funds Management Ltd. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 629.683M in assets, with a quarterly growth rate of 21.73% and a 2-quarter average growth rate of 15.43%. The portfolio is managed by Oshrat Levi, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
MLYS
Mineralys Therapeutics Inc
Recent Activity
Increased 198.44%
5.77%
$36.3M
1.34M shares@ $27.09 avg price
TEVA
Teva Pharmaceutical-sp Adr
Recent Activity
Increased 1.2%
5.44%
$34.246M
1.137M shares@ $30.12 avg price
TSEM
Tower Semiconductor Ltd
Recent Activity
Increased 18.96%
4.07%
$25.574M
145,735 shares@ $175.49 avg price
XBI
Spdr S&p Biotech Etf
Recent Activity
Increased 185.72%
4.06%
$25.546M↓ Put
200,000 shares@ $127.74 avg price
NVMI
Nova Ltd
Recent Activity
Increased 11.54%
3.69%
$23.176M
53,366 shares@ $434.28 avg price
CYTK
Cytokinetics Inc
Recent Activity
Increased 226.14%
3.14%
$19.715M
299,117 shares@ $65.92 avg price
BBIO
Bridgebio Pharma Inc
Recent Activity
Increased 127.62%
2.9%
$18.212M
245,246 shares@ $74.27 avg price
BIIB
Biogen Inc
Recent Activity
Decreased -2.33%
2.7%
$16.963M
92,526 shares@ $183.34 avg price
RARE
Ultragenyx Pharmaceutical In
Recent Activity
Increased 24.4%
2.7%
$16.956M
809,333 shares@ $20.95 avg price
SNDX
Syndax Pharmaceuticals Inc
Recent Activity
Decreased -4.98%
2.69%
$16.926M
724,563 shares@ $23.37 avg price

1-10 of 95